December 9, 2019
Winter holidays closure information for Operations offices, SDMC offices, and McKesson's Clinical Research Services. Read more
Winter holidays closure information for Biospecimen Banks and Serum Bank. Read more
Columbus Biospecimen Bank temporary closure on December 13. Read more
November 18, 2019
Thanksgiving closure information for Operations offices, SDMC offices, and McKesson's Clinical Research Services. Read more
Thanksgiving closure information for Biospecimen Banks and Serum Bank. Read more
November 4, 2019
Veteran's Day Closure information for Philadelphia East Operations, Buffalo SDMC, and the Biospecimen Bank in San Francisco. Read more
October 22, 2019
We mourn the passing of Bernard Fisher, MD (August 23, 1918 – October 16, 2019). He was a Distinguished Service Professor of Surgery at University of Pittsburgh, and founding member and past chairman of the NSABP. His profound research changed & improved the standard of care for women with breast cancer. We extend our deepest sympathies to his family.
Condolences to the family may be directed to the following address:
The Fisher Family
Pittsburgh, PA 15217
E-mail condolences may be sent to Dr. Beth Fisher at Bfisher917@gmail.com.
Click here to view Dr. Fisher's legacy.com obituary which includes information where contributions can be made in his honor.
October 4, 2019
NRG Oncology, in partnership with the RTOG Foundation, NSABP Foundation, and GOG Foundation, seek to support attendees to the NRG Oncology Semi-annual meeting occurring January 9-11, 2020 at the Marriott Marquis in Houston, Texas. Meeting registration will be opening soon! Applications for travel awards are due by the close of business October 25, 2019 (10/25/2019) and applicants will be notified by November 22, 2019 (11/22/2019) if they have been selected for an award. The travel award application can be found here.
September 19, 2019
The NRG Oncology Protocol Support Committee will be accepting applications until October 21, 2019. Read more
A Letter from the NRG Oncology Group Chairs on Rare Tumor Trials Read more
September 12, 2019
NRG Oncology Highlighted at ASTRO 2019, with all 4 ASTRO Plenary Session Talks Featuring NRG Oncology Research Read more
August 26, 2019
Labor Day Holiday Closures. Read more
July 24, 2019
NRG Oncology is seeking an experienced Patient Advocate to serve as Chair for its Patient Advocate Committee Read more
July 1, 2019 UPDATED
Independence Day Holiday Closures for Operations, SDMCs, Biospecimen Banks, Serum Bank, and McKesson Clinical Research Services. Read more
May 20, 2019
Memorial Day closures for Operations, SDMCs, Biospecimen Banks, Serum Bank, and McKesson Clinical Research Services. Read more
May 3, 2019
Patient Reported Outcomes: Upping the game for PRO methods and
design in clinical trials
NRG Oncology will be holding a workshop at the NRG Semiannual
Meeting related to improving statistical methods to meet study goals, analyzing
longitudinal PRO data as well as a panel discussion with NCORP PIs. This
session will be held on Thursday, July 18, 2019 from 1-5 pm ET and will be open
to all attendees. More information on the session and agenda will be released
April 23, 2019
Project Team Member Application – Abemaciclib
Applicants, please submit the form to the NRG protocol development office by COB Monday, May 6, 2019. NRG Oncology will submit the application to CTEP by the deadline of May 13, 2019.
April 17, 2019
NRG Oncology SDMC Awarded NCI Funding for Next 6 Years with ‘Outstanding’ Score
The NRG Oncology Statistics and Data Management Center (SDMC) was notified that the center will be awarded six more years of funding from the National Cancer Institute (NCI) and will continue to serve the NCI National Clinical Trials Network (NCTN) group NRG Oncology. The total amount of funding requested for the six year effort was $68.9 million. During the peer review grant renewal process, the NRG Oncology SDMC was ranked within the “Outstanding” range with a score of 18. Read more
April 16, 2019
NRG Oncology Awarded NCI Funding for Next 6 Years, Receives "Exceptional" Score
NRG Oncology, a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group conducting practice-changing clinical and translational research, has been awarded funding of $16.5 Million by the NCI for the next six years to continue its work as a lead protocol organization (LPO) program. During the peer review grant renewal process, NRG Oncology received the “exceptional” score of 16. Read more
March 5, 2019
Project Team Member Application – BAY 1895344
Applicants, please submit the form to the NRG protocol development office by COB Tuesday, March 19, 2019. NRG Oncology will submit the application to CTEP by the deadline of March 26, 2019.
February 21, 2019
NRG Oncology NCORP Pilot ProjectsNRG Oncology NCORP is soliciting PILOT projects for applications focused on NRG NCORP Cancer Prevention and Control (CPC) priorities that will provide data that will directly lead to future Phase II-III CPC concepts. As put forward in our core grant, CPC priorities for funding include cancer prevention research and cancer control investigation aimed at understanding and/or ameliorating the symptoms and toxicity related to:
- Neurocognitive function
- Gender specific symptom reduction
- Behavioral interventions
- Treatment dose alterations or delivery
- Cancer risk reduction
- Chemotherapy induced peripheral neuropathy
For full details read more
NRG Oncology NCORP solicits PILOT projects addressing NRG NCORP Cancer Care Delivery Research (CCDR) priorities. CCDR funding priorities are:
- Implementation and dissemination interventions related to guideline based care:
- Use of tumor DNA sequencing prior to prescribing targeted therapies(<1/4 of CCDR practices report routine use);
- Integrating patient-reported outcomes into clinical practice (extends survival);
- Enhance access to proven survivorship and palliative care strategies optimizing survivor and family quality of life;
- Optimize screening strategies based on disease risk including patients in the post-treatment surveillance phase of care; and
- Implement evidence-based symptom management strategies addressing patients’ needs during both active adjuvant and palliative treatment.
Patient-reported outcomes (PROs) related to symptom management: The CCDR committee will prioritize proposals including the PRO-CTCAE in NRG NCORP trials, and improve compliance and data capture. The CCDR committee also encourages studies employing technology or apps to standardized PRO variables across EHR, registry, and claims data systems.
For full details read more
NRG Oncology Strategic Planning Debrief
NRG Oncology makes plans for its continued success as leaders and stakeholders across the organization gathered December 14-15, 2018 to explore potential focus areas and goals for the organization.
Open the Special Report broadcast
Martin Luther King Jr Holiday Closures
MLK Day closures for NRG Oncology offices and banks. Read more